Your browser doesn't support javascript.
loading
Profile of moxifloxacin drug interactions.
Stass, H; Kubitza, D.
Afiliação
  • Stass H; Institute of Clinical Pharmacology, Bayer AG, Building 470, D-42096 Wuppertal, Germany. Heino.Stass.hs@bayer-ag.de
Clin Infect Dis ; 32 Suppl 1: S47-50, 2001 Mar 15.
Article em En | MEDLINE | ID: mdl-11249829
We report a brief description of the interaction profile of moxifloxacin. After oral administration, the absorption of moxifloxacin was unaffected by ranitidine or by food consumption. Drugs containing multivalent cations (e.g., Mg(++), Al(+++), and Fe(++), but not Ca(++)) impaired absorption. No clinically relevant effect of moxifloxacin was seen on the pharmacokinetics of digoxin under combination steady state conditions. Also, moxifloxacin did not affect the pharmacokinetics of theophylline or vice versa. This result, plus further data proving lack of interaction with glyburide, warfarin, and oral contraceptives, confirms the absence of metabolic interactions involving the cytochrome P-450 system, as previously reported. Concomitant administration of probenecid did not affect the elimination of moxifloxacin. Moxifloxacin thus has a unique drug interaction profile that is advantageous for its safe use.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Compostos Aza / Fluoroquinolonas / Anti-Infecciosos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Ano de publicação: 2001 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Compostos Aza / Fluoroquinolonas / Anti-Infecciosos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Ano de publicação: 2001 Tipo de documento: Article